Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 27.6B | 28.5B | 23.6B |
Cost of revenue | — | 7.4B | 8.9B | 6.2B |
Gross profit | — | 20.2B | 19.6B | 17.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | — | 5.6B | 8.1B | 7.3B |
Non operating interest income | ||||
Income | — | 380M | 300M | 235M |
Expense | — | 46M | 47M | 47M |
Other income expense | — | — | — | — |
Pretax income | — | 5.6B | 8.3B | 7.8B |
Tax provision | — | 4.1B | 2.6B | 2.2B |
Net income | — | 1.5B | 5.7B | 5.6B |
Basic EPS | 43.6 | — | — | — |
Diluted EPS | 42.9 | — | — | — |
Basic average shares | 236.1M | — | — | — |
Diluted average shares | 239.9M | — | — | — |
EBITDA | — | 5.8B | 8.3B | 7.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -40M | -36M | -28M |
Preferred stock dividends | — | 0 | 0 | 0 |